RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 113 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 3.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,000 | -35.3% | 4,747 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | +30.8% | 4,747 | -16.2% | 0.00% | – |
| Q2 2016 | $13,000 | -13.3% | 5,663 | -23.7% | 0.00% | – |
| Q1 2016 | $15,000 | 0.0% | 7,420 | +48.0% | 0.00% | – |
| Q4 2015 | $15,000 | -11.8% | 5,013 | -28.3% | 0.00% | – |
| Q3 2015 | $17,000 | -19.0% | 6,995 | +7.8% | 0.00% | – |
| Q2 2015 | $21,000 | -43.2% | 6,490 | -59.9% | 0.00% | – |
| Q4 2014 | $37,000 | +8.8% | 16,197 | -7.9% | 0.00% | – |
| Q3 2014 | $34,000 | -46.9% | 17,594 | 0.0% | 0.00% | – |
| Q2 2014 | $64,000 | +10.3% | 17,594 | +17.0% | 0.00% | – |
| Q1 2014 | $58,000 | 0.0% | 15,035 | -12.7% | 0.00% | – |
| Q2 2013 | $58,000 | – | 17,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |